RhumbLine Advisers’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.9M Buy
389,940
+16,085
+4% +$531K 0.01% 945
2025
Q1
$15M Sell
373,855
-10,028
-3% -$403K 0.01% 842
2024
Q4
$18.1M Buy
383,883
+5,207
+1% +$245K 0.02% 753
2024
Q3
$20M Sell
378,676
-581
-0.2% -$30.7K 0.02% 712
2024
Q2
$20.5M Buy
379,257
+72,618
+24% +$3.93M 0.02% 653
2024
Q1
$21.5M Buy
306,639
+24,797
+9% +$1.74M 0.02% 669
2023
Q4
$23.5M Buy
281,842
+6,973
+3% +$582K 0.02% 586
2023
Q3
$8.1M Buy
274,869
+3,005
+1% +$88.5K 0.01% 1090
2023
Q2
$8.87M Buy
271,864
+12,766
+5% +$416K 0.01% 1072
2023
Q1
$9.12M Buy
259,098
+11,640
+5% +$410K 0.01% 1000
2022
Q4
$11.3M Buy
247,458
+7,486
+3% +$343K 0.02% 867
2022
Q3
$11.6M Buy
239,972
+22,124
+10% +$1.07M 0.02% 815
2022
Q2
$8.56M Buy
217,848
+15,775
+8% +$620K 0.01% 977
2022
Q1
$7.44M Buy
202,073
+14,552
+8% +$536K 0.01% 1092
2021
Q4
$8.55M Buy
187,521
+525
+0.3% +$23.9K 0.01% 1070
2021
Q3
$6.68M Sell
186,996
-8,605
-4% -$308K 0.01% 1172
2021
Q2
$3.87M Sell
195,601
-7,616
-4% -$151K 0.01% 1575
2021
Q1
$4.73M Buy
203,217
+4,538
+2% +$106K 0.01% 1431
2020
Q4
$4.13M Buy
198,679
+12,175
+7% +$253K 0.01% 1466
2020
Q3
$4.04M Buy
186,504
+12,185
+7% +$264K 0.01% 1292
2020
Q2
$4.11M Sell
174,319
-6,314
-3% -$149K 0.01% 1320
2020
Q1
$2.13M Buy
180,633
+3,406
+2% +$40.2K ﹤0.01% 1511
2019
Q4
$1.88M Buy
177,227
+11,225
+7% +$119K ﹤0.01% 1824
2019
Q3
$1.89M Buy
166,002
+5,294
+3% +$60.2K ﹤0.01% 1773
2019
Q2
$1.81M Buy
160,708
+13,651
+9% +$154K ﹤0.01% 1799
2019
Q1
$1.19M Sell
147,057
-977
-0.7% -$7.91K ﹤0.01% 1958
2018
Q4
$936K Buy
148,034
+24,169
+20% +$153K ﹤0.01% 2044
2018
Q3
$1.22M Buy
123,865
+4,035
+3% +$39.7K ﹤0.01% 1912
2018
Q2
$995K Buy
119,830
+9,918
+9% +$82.4K ﹤0.01% 2014
2018
Q1
$791K Buy
109,912
+4,392
+4% +$31.6K ﹤0.01% 2040
2017
Q4
$860K Buy
105,520
+17,464
+20% +$142K ﹤0.01% 2012
2017
Q3
$1.28M Buy
88,056
+5,470
+7% +$79.3K ﹤0.01% 1859
2017
Q2
$999K Buy
82,586
+43,456
+111% +$526K ﹤0.01% 1954
2017
Q1
$503K Buy
39,130
+1,133
+3% +$14.6K ﹤0.01% 2239
2016
Q4
$462K Buy
37,997
+3,162
+9% +$38.4K ﹤0.01% 2270
2016
Q3
$320K Sell
34,835
-5,860
-14% -$53.8K ﹤0.01% 2452
2016
Q2
$386K Sell
40,695
-2,501
-6% -$23.7K ﹤0.01% 2373
2016
Q1
$305K Buy
43,196
+2,580
+6% +$18.2K ﹤0.01% 2518
2015
Q4
$425K Buy
40,616
+720
+2% +$7.53K ﹤0.01% 2346
2015
Q3
$267K Buy
39,896
+1,831
+5% +$12.3K ﹤0.01% 2625
2015
Q2
$256K Sell
38,065
-8,565
-18% -$57.6K ﹤0.01% 2757
2015
Q1
$316K Buy
46,630
+1,300
+3% +$8.81K ﹤0.01% 2580
2014
Q4
$363K Buy
45,330
+4,100
+10% +$32.8K ﹤0.01% 2474
2014
Q3
$145K Hold
41,230
﹤0.01% 2863
2014
Q2
$197K Buy
41,230
+26,003
+171% +$124K ﹤0.01% 2846
2014
Q1
$145K Buy
15,227
+3,850
+34% +$36.7K ﹤0.01% 2863
2013
Q4
$74K Buy
11,377
+1,100
+11% +$7.16K ﹤0.01% 2981
2013
Q3
$78K Sell
10,277
-223
-2% -$1.69K ﹤0.01% 2953
2013
Q2
$121K Buy
+10,500
New +$121K ﹤0.01% 3196